- Home
- BHIL vs RVPH Comparison
BHIL vs RVPH Comparison
Compare BHIL & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHIL
- RVPH
- Stock Information
- Founded
- BHIL 2012
- RVPH 2006
- Country
- BHIL United States
- RVPH United States
- Employees
- BHIL N/A
- RVPH N/A
- Industry
- BHIL Packaged Foods
- RVPH Biotechnology: Pharmaceutical Preparations
- Sector
- BHIL Consumer Staples
- RVPH Health Care
- Exchange
- BHIL Nasdaq
- RVPH Nasdaq
- Market Cap
- BHIL 38.8M
- RVPH 37.1M
- IPO Year
- BHIL N/A
- RVPH N/A
- Fundamental
- Price
- BHIL $7.36
- RVPH $1.50
- Analyst Decision
- BHIL
- RVPH Strong Buy
- Analyst Count
- BHIL 0
- RVPH 5
- Target Price
- BHIL N/A
- RVPH $14.50
- AVG Volume (30 Days)
- BHIL 16.3K
- RVPH 242.1K
- Earning Date
- BHIL 11-07-2024
- RVPH 11-12-2024
- Dividend Yield
- BHIL N/A
- RVPH N/A
- EPS Growth
- BHIL N/A
- RVPH N/A
- EPS
- BHIL N/A
- RVPH N/A
- Revenue
- BHIL $456,091,000.00
- RVPH N/A
- Revenue This Year
- BHIL N/A
- RVPH N/A
- Revenue Next Year
- BHIL N/A
- RVPH N/A
- P/E Ratio
- BHIL N/A
- RVPH N/A
- Revenue Growth
- BHIL 55.33
- RVPH N/A
- 52 Week Low
- BHIL $4.41
- RVPH $0.60
- 52 Week High
- BHIL $16.66
- RVPH $6.80
- Technical
- Relative Strength Index (RSI)
- BHIL 62.57
- RVPH 66.56
- Support Level
- BHIL $6.59
- RVPH $1.15
- Resistance Level
- BHIL $7.10
- RVPH $1.25
- Average True Range (ATR)
- BHIL 0.20
- RVPH 0.12
- MACD
- BHIL 0.01
- RVPH 0.02
- Stochastic Oscillator
- BHIL 89.53
- RVPH 92.31
About BHIL Benson Hill Inc.
Benson Hill Inc is an ag-tech company specializing in soy protein innovation. The company has one business segment Ingredient. The company focuses on seed innovation through proprietary germplasm and the CropOS platform. This platform integrates protein, genomic, and strategic data for predictive breeding using AI and ML. They operate a Crop Accelerator for rapid prototyping. Benson Hill is developing a seed portfolio for protein ingredients, aquaculture, specialty animal feed, and vegetable oils. The company's revenue can be disaggregated into product categories: Proprietary and Non-Proprietary. Proprietary revenue is defined as any sale of a proprietary bean. Non-Proprietary revenue is all other revenue from non-Proprietary sources.
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.